Tg Therapeutics (TGTX) EBT (2016 - 2025)
Historic EBT for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $25.9 million.
- Tg Therapeutics' EBT rose 50705.25% to $25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.8 million, marking a year-over-year increase of 73197.7%. This contributed to the annual value of $25.6 million for FY2024, which is 9594.24% up from last year.
- Per Tg Therapeutics' latest filing, its EBT stood at $25.9 million for Q3 2025, which was up 50705.25% from $30.9 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' EBT ranged from a high of $113.9 million in Q3 2023 and a low of -$94.0 million during Q4 2021
- For the 5-year period, Tg Therapeutics' EBT averaged around -$25.2 million, with its median value being -$36.6 million (2022).
- Per our database at Business Quant, Tg Therapeutics' EBT crashed by 9625.38% in 2024 and then surged by 50705.25% in 2025.
- Over the past 5 years, Tg Therapeutics' EBT (Quarter) stood at -$94.0 million in 2021, then grew by 14.49% to -$80.4 million in 2022, then surged by 82.55% to -$14.0 million in 2023, then soared by 281.47% to $25.5 million in 2024, then increased by 1.79% to $25.9 million in 2025.
- Its EBT stands at $25.9 million for Q3 2025, versus $30.9 million for Q2 2025 and $5.5 million for Q1 2025.